Cited 2 time in
How Can We Treat Cancer Disease Not Cancer Cells?
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Kyu-Won | - |
| dc.contributor.author | Lee, Su-Jae | - |
| dc.contributor.author | Kim, Woo-Young | - |
| dc.contributor.author | Seo, Ji Hae | - |
| dc.contributor.author | Lee, Ho-Young | - |
| dc.date.accessioned | 2021-08-02T15:52:00Z | - |
| dc.date.available | 2021-08-02T15:52:00Z | - |
| dc.date.issued | 2017-01 | - |
| dc.identifier.issn | 1598-2998 | - |
| dc.identifier.issn | 2005-9256 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/21244 | - |
| dc.description.abstract | Since molecular biology studies began, researches in biological science have centered on proteins and genes at molecular level of a single cell. Cancer research has also focused on various functions of proteins and genes that distinguish cancer cells from normal cells. Accordingly, most contemporary anticancer drugs have been developed to target abnormal characteristics of cancer cells. Despite the great advances in the development of anticancer drugs, vast majority of patients with advanced cancer have shown grim prognosis and high rate of relapse. To resolve this problem, we must reevaluate our focuses in current cancer research. Cancer should be considered as a systemic disease because cancer cells undergo a complex interaction with various surrounding cells in cancer tissue and spread to whole body through metastasis under the control of the systemic modulation. Human body relies on the cooperative interaction between various tissues and organs, and each organ performs its specialized function through tissue-specific cell networks. Therefore, investigation of the tumor-specific cell networks can provide novel strategy to overcome the limitation of current cancer research. This review presents the limitations of the current cancer research, emphasizing the necessity of studying tissue-specific cell network which could be a new perspective on treating cancer disease, not cancer cells. | - |
| dc.format.extent | 9 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 대한암학회 | - |
| dc.title | How Can We Treat Cancer Disease Not Cancer Cells? | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.4143/crt.2016.606 | - |
| dc.identifier.scopusid | 2-s2.0-85010280573 | - |
| dc.identifier.wosid | 000391899800001 | - |
| dc.identifier.bibliographicCitation | Cancer Research and Treatment, v.49, no.1, pp 1 - 9 | - |
| dc.citation.title | Cancer Research and Treatment | - |
| dc.citation.volume | 49 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 9 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART002190063 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.subject.keywordPlus | MICROENVIRONMENTAL REGULATION | - |
| dc.subject.keywordPlus | PROGRESSION | - |
| dc.subject.keywordPlus | ANGIOGENESIS | - |
| dc.subject.keywordPlus | HISTORY | - |
| dc.subject.keywordAuthor | Cancer cells | - |
| dc.subject.keywordAuthor | Cancer disease | - |
| dc.subject.keywordAuthor | Metastasis | - |
| dc.subject.keywordAuthor | Systemic disease | - |
| dc.subject.keywordAuthor | Tissue-specific cell network | - |
| dc.identifier.url | https://www.e-crt.org/journal/view.php?doi=10.4143/crt.2016.606 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
